Richter Financial Statements From 2010 to 2024
| RIG2 Stock | EUR 25.80 0.40 1.57% |
Check Richter Gedeon financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Richter Gedeon's main balance sheet or income statement drivers, such as , as well as many indicators such as . Richter financial statements analysis is a perfect complement when working with Richter Gedeon Valuation or Volatility modules.
Richter |
Richter Gedeon Vegyszeti Company Return On Equity Analysis
Richter Gedeon's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Richter Gedeon Return On Equity | 0.25 |
Most of Richter Gedeon's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Richter Gedeon Vegyszeti is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Richter Gedeon Vegyszeti has a Return On Equity of 0.247. This is 101.03% lower than that of the Healthcare sector and 29.43% lower than that of the Drug Manufacturers - Specialty & Generic industry. The return on equity for all Germany stocks is 179.68% lower than that of the firm.
Richter Gedeon Vegyszeti Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Richter Gedeon's current stock value. Our valuation model uses many indicators to compare Richter Gedeon value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Richter Gedeon competition to find correlations between indicators driving Richter Gedeon's intrinsic value. More Info.Richter Gedeon Vegyszeti is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.38 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Richter Gedeon Vegyszeti is roughly 2.62 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Richter Gedeon's earnings, one of the primary drivers of an investment's value.About Richter Gedeon Financial Statements
Richter Gedeon stakeholders use historical fundamental indicators, such as Richter Gedeon's revenue or net income, to determine how well the company is positioned to perform in the future. Although Richter Gedeon investors may analyze each financial statement separately, they are all interrelated. For example, changes in Richter Gedeon's assets and liabilities are reflected in the revenues and expenses on Richter Gedeon's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Richter Gedeon Vegyszeti. Please read more on our technical analysis and fundamental analysis pages.
Richter Gedeon Vegyszeti Gyr Nyilvnosan Mukdo Rt. researches, develops, manufactures, markets, and sells pharmaceutical products worldwide. The company was founded in 1901 and is headquartered in Budapest, Hungary. RICHT GEDE operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 12869 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Richter Stock
Richter Gedeon financial ratios help investors to determine whether Richter Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Richter with respect to the benefits of owning Richter Gedeon security.